HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.
about
HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Analysis of HSP90 Expression Is Valuable in the Differential Diagnosis of Ocular Surface Squamous Lesions.
P2860
HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@en
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@nl
type
label
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@en
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@nl
prefLabel
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@en
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@nl
P2093
P2860
P356
P1476
HSP90 Inhibitor SNX5422/2112 T ...... Neck Squamous Cell Carcinoma.
@en
P2093
Carter Van Waes
Chris Gouveia
Christian Freudlsperger
James B Mitchell
Jay A Friedman
Michael Hu
Pattatheyil Arun
Robert Vander Broek
Stephanie C Wise
Vishnu R Kannabiran
P2860
P304
P356
10.1593/TLO.13292
P577
2013-08-01T00:00:00Z